Dexcom | DXCM - 市值



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 32.51B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


市值 更改 日
Abbott USD 158.05B 20.36B 2026-06
Align Technology USD 12.08B 198M 2026-06
AtriCure USD 1.42B 28M 2026-06
Baxter International USD 11.01B 2.34B 2026-06
Becton, Dickinson and Co. USD 51.35B 9.65B 2026-08
Boston Scientific USD 63.44B 29.82B 2026-06
Cooper Companies USD 12.27B 3.68B 2026-03
Dexcom USD 25.99B 1.82B 2026-06
Edwards Lifesciences USD 52.09B 5.92B 2026-06
Globus Medical USD 10.98B 251M 2026-08
Insulet USD 9.32B 1.23B 2026-08
Integra LifeSciences USD 1.4B 664M 2026-06
J&J USD 611.36B 32.21B 2026-06
Merit Medical Systems USD 4.14B 25M 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Stryker USD 120.7B 5.15B 2026-06
Tandem Diabetes Care USD 1.23B 199M 2026-08
Teleflex USD 6.54B 924M 2026-08
West Pharmaceutical Services USD 25.36B 7.3B 2026-06
WK Kellogg Co USD 14.82B 1.46B 2026-08
Zimmer Biomet Holdings USD 20.17B 3.51B 2026-08